Cristina Rondinone
Net worth: - $ as of 2023-12-30
Career history of Cristina Rondinone
Former positions of Cristina Rondinone
Companies | Position | Start | End |
---|---|---|---|
AXCA HEALPAR | Director/Board Member | 2018-06-26 | 2023-10-31 |
Independent Dir/Board Member | 2018-06-26 | 2023-10-31 | |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | President | 2019-08-31 | 2020-05-31 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 2011-02-28 | 2019-08-31 |
University of Gothenburg | Corporate Officer/Principal | - | - |
Training of Cristina Rondinone
Universidad de Buenos Aires | Doctorate Degree |
Statistics
International
United States | 4 |
Argentina | 2 |
Sweden | 2 |
Operational
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
AXCA HEALPAR | Health Technology |
Private companies | 2 |
---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Cristina Rondinone
- Experience